Open Access
Research Article
Issue
Parasite
Volume 26, 2019
Article Number 63
Number of page(s) 6
DOI https://doi.org/10.1051/parasite/2019063
Published online 05 November 2019
  1. Ballart C, Alcover MM, Picado A, Nieto J, Castillejo S, Portus M, Gallego M. 2013. First survey on canine leishmaniasis in a non classical area of the disease in Spain (Lleida, Catalonia) based on a veterinary questionnaire and a cross-sectional study. Preventive Veterinary Medicine, 109, 116–127. [CrossRef] [PubMed] [Google Scholar]
  2. Bergman DK. 1996. Mouthparts and feeding mechanisms of haematophagous arthropods, in The immunology of host-ectoparasitic arthropod relationships, Wikel SK, Editor. CAB International: Wallingford, UK. p. 38–45. [Google Scholar]
  3. Beugnet F, Liebenberg J, Halos L. 2015. Comparative efficacy of two oral treatments for dogs containing either afoxolaner or fluralaner against Rhipicephalus sanguineus sensu lato and Dermacentor reticulatus. Veterinary Parasitology, 209, 142–145. [CrossRef] [PubMed] [Google Scholar]
  4. Beugnet F, Liebenberg J, Halos L. 2015. Comparative speed of efficacy against Ctenocephalides felis of two oral treatments for dogs containing either afoxolaner or fluralaner. Veterinary Parasitology, 207, 297–301. [CrossRef] [PubMed] [Google Scholar]
  5. Beugnet F, de Vos C, Liebenberg J, Halos L, Larsen D, Fourie J. 2016. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei. Parasite, 23, 26. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Beugnet F, Halos L, Larsen D, de Vos C. 2016. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis. Parasite, 23, 14. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  7. Beugnet F, Halos L, Guillot J. 2018. Textbook of clinical parasitology in dogs and cats. Zaragoza, Spain: Servet Editions. p. 166–174. [Google Scholar]
  8. Carithers D, Crawford J, de Vos C, Lotriet A, Fourie J. 2016. Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs. Parasites & Vectors, 9, 635. [CrossRef] [PubMed] [Google Scholar]
  9. Colange H. 2011. Contribution à l’étude du repas sanguin de Phlebotomus perniciosus (Diptera : Psychodidae). Toulouse, France: Thèse d’exercice, Médecine vétérinaire, École Nationale Vétérinaire de Toulouse – ENVT, 78 p. [Google Scholar]
  10. Dereure J, Vanwambeke SO, Malé P, Martinez S, Pratlong F, Balard Y, Dedet JP. 2009. The potential effects of global warming on changes in canine leishmaniasis in a focus outside the classical area of the disease in southern France. Vector-Borne Zoonotic Diseases, 9, 687–694. [CrossRef] [Google Scholar]
  11. Dolmatova AV, Demina NA. 1971. Les phlébotomes (Phlebotominae) et les maladies qu’ils transmettent. Paris, France: Office de la Recherche Scientifique et Technique d’Outre Mer (ORSTOM), 168 p. [Google Scholar]
  12. European Medicines Agency. 2014. Nexgard® summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/veterinary/002729/WC500164067.pdf. [Google Scholar]
  13. Gomez SA, Picado A. 2017. Systemic insecticides used in dogs: potential candidates for phlebotomine vector control? Tropical Medicine & International Health, 22, 755–764. [CrossRef] [Google Scholar]
  14. Gomez SA, Lucientes J, Castillo JA, Peris MP, Delacour S, Ortega P, Oropeza RV, Picado A. 2018. A randomized, blinded, controlled trial to assess sand fly mortality of fluralaner administered orally in dogs. Parasites & Vectors, 11, 627. [CrossRef] [PubMed] [Google Scholar]
  15. Grammicia M. 2011. Recent advances in leishmaniosis in pet animals: epidemiology, diagnostics and anti-vectorial prophylaxis. Veterinary Parasitology, 8, 23–30. [Google Scholar]
  16. Grammicia M, Gradoni L. 2005. The current status of zoonotic leishmaniases and approaches to disease control. International Journal for Parasitology, 35, 1169–1180. [CrossRef] [PubMed] [Google Scholar]
  17. Halos L, Lebon W, Chalvet-Monfray K, Larsen D, Beugnet F. 2014. Immediate efficacy and persistent speed of kill of a novel oral formulation of afoxolaner (NexGard®) against induced infestations with Ixodes ricinus ticks. Parasites & Vectors, 7, 452. [CrossRef] [PubMed] [Google Scholar]
  18. Halos L, Carithers DS, Solanki R, Stanford H, Gross SJ. 2015. Preference of dogs between two commercially available oral formulations of ectoparasiticide containing isoxazolines, afoxolaner or fluralaner. Scientific Research Publishing, 5, 25–29. [Google Scholar]
  19. Killick-Kendrick R. 1979. Biology of Leishmania in phlebotomine sandflies, in Biology of the Kinetoplastida, Lumsden WH, Evans DA, Editors. Academic Press: London. p. 395–460. [Google Scholar]
  20. Killick-Kendrick R. 1999. The biology and control of Phlebotomine sand flies. Clinics in Dermatology, 17, 279–289. [CrossRef] [PubMed] [Google Scholar]
  21. Letendre L, Huang R, Kvaternick V, Harriman J, Drag M, Soll M. 2014. The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs. Veterinary Parasitology, 201, 190–197. [CrossRef] [PubMed] [Google Scholar]
  22. Liebenberg J, Fourie J, Lebon W, Larsen D, Halos L, Beugnet F. 2017. Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard®. Parasite, 24, 39. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  23. Maia C, Cardoso L. 2015. Spread of Leishmania infantum in Europe with dog travelling. Veterinary Parasitology, 30, 2–11. [Google Scholar]
  24. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. 2013. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Medical and Veterinary Entomology, 27, 123–147. [CrossRef] [PubMed] [Google Scholar]
  25. Miró G, Checa R, Montoya A, Hernandez L, Dado D, Galvez R. 2012. Current situation of Leishmania infantum infection in shelter dogs in northern Spain. Parasites & Vectors, 5, 60. [CrossRef] [PubMed] [Google Scholar]
  26. Otranto D, Dantas-Torres F. 2013. The prevention of canine leishmaniasis and its impact on public health. Trends in Parasitology, 29, 339–345. [CrossRef] [PubMed] [Google Scholar]
  27. Palatnik-de-Soussa CB, Day MJ. 2011. One health: the global challenge of epidemic and endemic leishmaniasis. Parasite & Vectors, 4, 197. [CrossRef] [Google Scholar]
  28. Shoop WL, Hartline EJ, Gould BR, Waddell ME, McDowell RG, Kinney JB, Lahm GP, Long JK, Xu M, Wagerle T, Jones GS, Dietrich RF, Cordova D, Schroeder ME, Rhoades DF, Benner EA, Confalone PN. 2014. Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs. Veterinary Parasitology, 201, 179–189. [CrossRef] [PubMed] [Google Scholar]
  29. Volf P, Volfova V. 2011. Establishment and maintenance of sand fly colonies. Journal of Vector Ecology, 36, S1–S9. [CrossRef] [Google Scholar]
  30. World Health Organization. 2010. Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. Geneva. (WHO Technical Report Series, 949). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.